Harvard Bioscience, Inc.
HBIO
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tisā¦ read more
Healthcare
Medical Instruments & Supplies
25 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$7.44
Price+5.09%
$0.36
1Y
Price
Market Cap
$33.556m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-17.7%
EBITDA Margin-16.5%
Net Profit Margin-5.2%
Free Cash Flow Margin-17.7%
EBITDA Margin-16.5%
Net Profit Margin-5.2%
Free Cash Flow MarginRevenue
$85.531m
-1.2%
1y CAGR-8.5%
3y CAGR-6.6%
5y CAGREarnings
-$9.784m
+82.7%
1y CAGR-179.2%
3y CAGR-118.4%
5y CAGREPS
-$2.20
+82.8%
1y CAGR-173.3%
3y CAGR-113.8%
5y CAGRBook Value
$10.046m
$77.938m
Assets$67.892m
Liabilities$44.122m
DebtDebt to Assets
56.6%
-23.6x
Debt to EBITDAFree Cash Flow
$1.475m
-73.7%
1y CAGR+72.9%
3y CAGR+748.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company